Pharmaceutical injectable solution comprising dopamine
US-2026091004-A1 · Apr 2, 2026 · US
Inst Nat Sante Rech Med patents
Inst Nat Sante Rech Med holds 3,142 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3,142 |
| Recent patents | 958 |
| First publication | Jan 1, 2015 |
| Latest publication | Apr 2, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
US-2026091033-A1 · Apr 2, 2026 · US
NRP-1 binding inhibitory peptides and uses thereof
US-12590122-B2 · Mar 31, 2026 · US
Radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-PD-1/PD-L1
US-12590949-B2 · Mar 31, 2026 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Pharmaceutical injectable solution comprising dopamine
US-2026091004-A1 · Apr 2, 2026 · US
Hybrid Molecule Comprising an Antibody FC Portion and at Least One Peptide Binding to a Self-Reactive Lymphocyte Involved in Autoimmune Dermatitis, and Uses Thereof
US-2026091122-A1 · Apr 2, 2026 · US
Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
US-2026091033-A1 · Apr 2, 2026 · US
NRP-1 binding inhibitory peptides and uses thereof
US-12590122-B2 · Mar 31, 2026 · US
Radiomics-based imaging tool to monitor tumor-lymphocyte infiltration and outcome in cancer patients treated by anti-PD-1/PD-L1
US-12590949-B2 · Mar 31, 2026 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 708 |
| A61K45/06 | 406 |
| A61K2039/505 | 312 |
| A61P43/00 | 278 |
| C07K2317/76 | 218 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 2,576 |
| Chemistry & Metallurgy | 2,059 |
| Physics | 947 |
| Cross-Sectional Technologies | 201 |
| Operations & Transport | 69 |
| Electricity | 37 |
| Textiles & Paper | 3 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Inst Nat Sante Rech Med have in patentsdb?
- Inst Nat Sante Rech Med is linked to 3,142 publications as assignee in our database.
- What technology areas does Inst Nat Sante Rech Med patent most?
- Top mapped technology areas by patent count: Human Necessities (2,576); Chemistry & Metallurgy (2,059); Physics (947).
- Is Inst Nat Sante Rech Med's patent activity growing?
- In our data, assignee counts were 345 in 2024 and 324 in 2025 (lower year over year).
- What are recent patents assigned to Inst Nat Sante Rech Med?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.